» Articles » PMID: 37426616

Effects of Maternal Calcium and Protein Intake on the Development and Bone Metabolism of Offspring Mice

Overview
Journal Open Life Sci
Specialty Biology
Date 2023 Jul 10
PMID 37426616
Authors
Affiliations
Soon will be listed here.
Abstract

Maternal nutrition is pivotal for offspring's growth and development. Insufficient or unbalanced nutrition may cause osteoporosis and other diseases. Protein and calcium are essential dietary nutrients for offspring's growth. However, the optimal contents of protein and calcium in maternal diet remain unclear. In the present study, we set four different protein and calcium content-pregnancy nutrition groups, including normal full-nutrient (Normal), low protein and low calcium (Pro-; Ca-), high protein and low calcium (Pro+; Ca-), and high protein and high calcium groups (Pro+; Ca+), to evaluate the weight gain of maternal mice as well as the weight, bone metabolism, and bone mineral density of offspring mice. When the vaginal plug is found, the female mouse will be kept in a single cage and fed with corresponding feed until delivery. The findings demonstrate that Pro-; Ca- diet affects the growth and development of offspring mice after birth. In addition, a low-calcium diet inhibits the growth of embryonic mice. Collectively, the present work further confirms the importance of protein and calcium in the maternal diet and deeply suggests their respective roles in different development stages.

Citing Articles

Fetal Growth Is Associated with Amniotic Fluid Antioxidant Capacity, Oxidative Stress, Minerals and Prenatal Supplementation: A Retrospective Study.

Kohzadi M, Kubow S, Koski K Antioxidants (Basel). 2025; 14(2).

PMID: 40002371 PMC: 11852346. DOI: 10.3390/antiox14020184.

References
1.
Ensrud K, Crandall C . Osteoporosis. Ann Intern Med. 2017; 167(3):ITC17-ITC32. DOI: 10.7326/AITC201708010. View

2.
Gluckman P, Hanson M . Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med. 2005; 9(5):419-25. DOI: 10.1016/j.siny.2004.03.001. View

3.
Eastell R, Szulc P . Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. 2017; 5(11):908-923. DOI: 10.1016/S2213-8587(17)30184-5. View

4.
. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021; 28(9):973-997. DOI: 10.1097/GME.0000000000001831. View

5.
Armas L, Recker R . Pathophysiology of osteoporosis: new mechanistic insights. Endocrinol Metab Clin North Am. 2012; 41(3):475-86. DOI: 10.1016/j.ecl.2012.04.006. View